Udwadia ZF, Singh P, Barkate H, Patil S, et al. Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial. Int J Infect Dis 2020 Nov 16. pii: S1201-9712(20)32453.
PMID: 33212256